Withdrawn: The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs

Mariska van den Berg; Susan Nijboer-Brinksma; Sophie Bos; Maarten van den Berge; David Lamb; Martijn van Faassen; Ido Kema; Reinoud Gosens; Loes Kistemaker

doi:10.1111/bph.15133

Withdrawn: The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs

Br J Pharmacol. 2020 Oct;177(20):4809. doi: 10.1111/bph.15133.

Authors

Mariska van den Berg^{1

2}, Susan Nijboer-Brinksma^{1

2}, Sophie Bos^{1

2}, Maarten van den Berge^{2

3}, David Lamb⁴, Martijn van Faassen⁵, Ido Kema⁵, Reinoud Gosens^{1

2}, Loes Kistemaker^{1

2}

Affiliations

¹ Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands.
² Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
³ Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
⁴ Immunology and Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
⁵ Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Abstract

The above article from the British Journal of Pharmacology, published online on May 20, 2020 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn due to a lack of full disclosure of the chemical structure of the novel TRPA1 antagonist BI01305834, by agreement between the Editor-in-Chief and John Wiley & Sons Inc on behalf of The British Pharmacology Society.

Publication types

Retracted Publication